Defining the System: Contributors to Exercise Limitations in Heart Failure

Heart Failure Clinics

Volumn 11, Issue 1, 2015, Pages 1-16

  Phillips, Shane A ^a   Vuckovic, Karen ^a   Cahalin, Lawrence P ^b   Baynard, Tracy ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiopulmonary; Exercise; Heart failure; Intolerance; Skeletal muscle; Vascular

Indexed keywords

ARTERIAL STIFFNESS; CHRONOTROPISM; ENDOTHELIAL DYSFUNCTION; EXERCISE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART PERFUSION; HEART RATE; HUMAN; INFLAMMATION; MUSCLE FUNCTION; MUSCLE METABOLISM; RESPIRATORY SYSTEM; REVIEW; SKELETAL MUSCLE; VASCULAR RESISTANCE; EXERCISE TOLERANCE; KINESIOTHERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

EXERCISE THERAPY; EXERCISE TOLERANCE; HEART FAILURE; HUMANS;

EID: 84922807558     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2014.08.009     Document Type: Review

References (131)

1. Arena R., Guazzi M., Myers J., et al. The prognostic utility of cardiopulmonary exercise testing stands the test of time in patients with heart failure. JCardiopulm Rehabil Prev 2012, 32(4):198-202.
2. Conraads V.M., Van Craenenbroeck E.M., De Maeyer C., et al. Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training. Heart Fail Rev 2013, 18(1):65-77.
3. Denolin H., Kuhn H., Krayenbuehl H.P., et al. The definition of heart failure. Eur Heart J 1983, 4(7):445-448.
4. Ennezat P.V., Lefetz Y., Marechaux S., et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. JCard Fail 2008, 14(6):475-480.
5. Haykowsky M.J., Brubaker P.H., John J.M., et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. JAm Coll Cardiol 2011, 58(3):265-274.
6. Kitzman D.W., Higginbotham M.B., Cobb F.R., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. JAm Coll Cardiol 1991, 17(5):1065-1072.
7. Abudiab M.M., Redfield M.M., Melenovsky V., et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15(7):776-785.
8. Borlaug B.A., Olson T.P., Lam C.S., et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. JAm Coll Cardiol 2010, 56(11):845-854.
9. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20):2138-2147.
10. Shibata S., Hastings J.L., Prasad A., et al. Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism. JAppl Phys 2011, 110(4):964-971.
11. Borlaug B.A., Nishimura R.A., Sorajja P., et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3(5):588-595.
12. Borlaug B.A., Jaber W.A., Ommen S.R., et al. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 2011, 97(12):964-969.
13. Westermann D., Kasner M., Steendijk P., et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008, 117(16):2051-2060.
14. Borlaug B.A. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J 2013, 78(1):20-32.
15. Skaluba S.J., Litwin S.E. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004, 109(8):972-977.
16. Borlaug B.A., Lam C.S., Roger V.L., et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. JAm Coll Cardiol 2009, 54(5):410-418.
17. Kurt M., Wang J., Torre-Amione G., et al. Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging 2009, 2(1):10-15.
18. Pagel P.S., Kehl F., Gare M., et al. Mechanical function of the left atrium: new insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology 2003, 98(4):975-994.
19. Patel D.A., Lavie C.J., Milani R.V., et al. Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction. Mayo Clin Proc 2011, 86(8):730-737.
20. Tan Y.T., Sanderson J.E. Forgotten atrial: driver of symptoms in heart failure with normal ejection fraction?. Heart 2012, 98(17):1261-1262.
21. Obokata M., Negishi K., Kurosawa K., et al. Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging 2013, 6(7):749-758.
22. Phan T.T., Abozguia K., Shivu G.N., et al. Increased atrial contribution to left ventricular filling compensates for impaired early filling during exercise in heart failure with preserved ejection fraction. JCard Fail 2009, 15(10):890-897.
23. Hammoudi N., Achkar M., Laveau F., et al. Left atrial volume predicts abnormal exercise left ventricular filling pressure. Eur J Heart Fail 2014, [Epub ahead of print].
24. Pina I.L., Apstein C.S., Balady G.J., et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003, 107(8):1210-1225.
25. Sullivan M.J., Hawthorne M.H. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995, 38(1):1-22.
26. Sullivan M.J., Cobb F.R. Central hemodynamic response to exercise in patients with chronic heart failure. Chest 1992, 101(5 Suppl):340S-346S.
27. Sullivan M.J., Knight J.D., Higginbotham M.B., et al. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989, 80(4):769-781.
28. Brubaker P.H., Kitzman D.W. Prevalence and management of chronotropic incompetence in heart failure. Curr Cardiol Rep 2007, 9(3):229-235.
29. Dresing T.J., Blackstone E.H., Pashkow F.J., et al. Usefulness of impaired chronotropic response to exercise as a predictor of mortality, independent of the severity of coronary artery disease. Am J Cardiol 2000, 86(6):602-609.
30. Lauer M.S., Francis G.S., Okin P.M., et al. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999, 281(6):524-529.
31. Brubaker P.H., Joo K.C., Stewart K.P., et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. JCardiopulm Rehabil 2006, 26(2):86-89.
32. Witte K.K., Cleland J.G., Clark A.L. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade. Heart 2006, 92(4):481-486.
33. Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. JAm Coll Cardiol 2009, 54(5):375-385.
34. Kishi T. Heart failure as an autonomic nervous system dysfunction. JCardiol 2012, 59(2):117-122.
35. Zhang D.Y., Anderson A.S. The sympathetic nervous system and heart failure. Cardiol Clin 2014, 32(1):33-45. vii.
36. Keller-Ross M.L., Johnson B.D., Joyner M.J., et al. Influence of the metaboreflex on arterial blood pressure in heart failure patients. Am Heart J 2014, 167(4):521-528.
37. Heusch G., Libby P., Gersh B., et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 2014, 383(9932):1933-1943.
38. van Heerebeek L., Borbely A., Niessen H.W., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113(16):1966-1973.
39. Patel B.M., Mehta A.A. Aldosterone and angiotensin: role in diabetes and cardiovascular diseases. Eur J Pharmacol 2012, 697(1-3):1-12.
40. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87(4):1285-1342.
41. van Heerebeek L., Franssen C.P., Hamdani N., et al. Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep 2012, 9(4):293-302.
42. Weber K.T., Sun Y., Tyagi S.C., et al. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. JMol Cell Cardiol 1994, 26(3):279-292.
43. Neef S., Maier L.S. Novel aspects of excitation-contraction coupling in heart failure. Basic Res Cardiol 2013, 108(4):360.
44. Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. JClin Invest 2007, 117(3):568-575.
45. Wilson J.R., Martin J.L., Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 1984, 53(9):1308-1315.
46. Andersen P., Saltin B. Maximal perfusion of skeletal muscle in man. JPhysiol 1985, 366:233-249.
47. Calbet J.A., Gonzalez-Alonso J., Helge J.W., et al. Cardiac output and leg and arm blood flow during incremental exercise to exhaustion on the cycle ergometer. JAppl Phys 2007, 103(3):969-978.
48. Duscha B.D., Schulze P.C., Robbins J.L., et al. Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 2008, 13(1):21-37.
49. Rowell L.B. Blood pressure regulation during exercise. Ann Med 1991, 23(3):329-333.
50. Borlaug B.A. Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases. Eur Heart J 2013, 34(19):1393-1395.
51. Kinugawa T., Kato M., Ogino K., et al. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. JCard Fail 2003, 9(4):318-324.
52. Lang C.C., Rayos G.H., Chomsky D.B., et al. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997, 96(1):238-245.
53. Notarius C.F., Ando S., Rongen G.A., et al. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 1999, 20(12):880-887.
54. Notarius C.F., Millar P.J., Murai H., et al. Inverse relationship between muscle sympathetic activity during exercise and peak oxygen uptake in subjects with and without heart failure. JAm Coll Cardiol 2014, 63(6):605-606.
55. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in congestive heart failure. Am Heart J 1993, 126:761-764.
56. Landmesser U., Spiekermann S., Dikalov S., et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002, 106(24):3073-3078.
57. Fichtlscherer S., Breuer S., Zeiher A.M. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation 2004, 110(14):1926-1932.
58. Vanhoutte P.M., Shimokawa H., Tang E.H., et al. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009, 196(2):193-222.
59. Laurindo F.R., Pedro M.A., Barbeiro H.V., et al. Vascular free radical release: exvivo and invivo evidence for a flow-dependent endothelial mechanism. Circ Res 1994, 1994(74):700-709.
60. Taddei S., Virdis A., Ghiadoni L., et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998, 97:2222-2229.
61. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. JAm Coll Cardiol 1998, 31(6):1352-1356.
62. Boo Y.C., Hwang J., Sykes M., et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 2002, 283(5):H1819-H1828.
63. Woodman C.R., Price E.M., Laughlin M.H. Shear stress induces eNOS mRNA expression and improves endothelium-dependent dilation in senescent soleus muscle feed arteries. JAppl Phys 2005, 98(3):940-946.
64. Ramsey M.W., Goodfellow J., Jones C.J., et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995, 92(11):3212-3219.
65. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990, 81(3):772-779.
66. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87(1):315-424.
67. Hambrecht R., Adams V., Erbs S., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003, 107(25):3152-3158.
68. Morra E.A., Zaniqueli D., Rodrigues S.L., et al. Long-term intense resistance training in men is associated with preserved cardiac structure/function, decreased aortic stiffness, and lower central augmentation pressure. JHypertens 2014, 32(2):286-293.
69. Mottram P.M., Haluska B.A., Leano R., et al. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005, 91(12):1551-1556.
70. Kitzman D.W., Herrington D.M., Brubaker P.H., et al. Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction. Hypertension 2013, 61(1):112-119.
71. Chae C.U., Pfeffer M.A., Glynn R.J., et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999, 281(7):634-639.
72. Lane A.D., Wu P.T., Kistler B., et al. Arterial stiffness and walk time in patients with end-stage renal disease. Kidney Blood Press Res 2013, 37(2-3):142-150.
73. Bonapace S., Rossi A., Cicoira M., et al. Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation 2003, 107(12):1603-1608.
74. Booth A.D., Wallace S., McEniery C.M., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004, 50(2):581-588.
75. Klocke R., Cockcroft J.R., Taylor G.J., et al. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003, 62(5):414-418.
76. Vlachopoulos C., Dima I., Aznaouridis K., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005, 112(14):2193-2200.
77. Conraads V.M., Bosmans J.M., Vrints C.J. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol 2002, 85(1):33-49.
78. Kinugawa T., Kato M., Ogino K., et al. Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. Int J Cardiol 2003, 87(1):83-90.
79. Kullo I.J., Seward J.B., Bailey K.R., et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005, 18(8):1123-1129.
80. Nagano M., Nakamura M., Sato K., et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005, 180(1):189-195.
81. Yasmin, McEniery C.M., Wallace S., et al. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24(5):969-974.
82. Venugopal S.K., Devaraj S., Yuhanna I., et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106(12):1439-1441.
83. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105(16):1890-1896.
84. Fernandez-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24(3):278-301.
85. Fernandez-Real J.M., Broch M., Vendrell J., et al. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Metab Disord 2003, 27(12):1552-1556.
86. Kalra L., Rambaran C., Chowienczyk P., et al. Ethnic differences in arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. Arterioscler Thromb Vasc Biol 2005, 25(11):2362-2367.
87. Guazzi M., Samaja M., Arena R., et al. Long-term use of sildenafil in the therapeutic management of heart failure. JAm Coll Cardiol 2007, 50(22):2136-2144.
88. Kitzman D.W., Brubaker P.H., Herrington D.M., et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. JAm Coll Cardiol 2013, 62(7):584-592.
89. Coats A.J., Clark A.L., Piepoli M., et al. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994, 72(2 Suppl):S36-39.
90. 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989, 80(5):1338-1346.
91. Drexler H., Riede U., Munzel T., et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992, 85(5):1751-1759.
92. Anker S.D., von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004, 90(4):464-470.
93. Fanzani A., Conraads V.M., Penna F., et al. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. JCachexia Sarcopenia Muscle 2012, 3(3):163-179.
94. Bonaldo P., Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013, 6(1):25-39.
95. Fulster S., Tacke M., Sandek A., et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013, 34(7):512-519.
96. Hambrecht R., Schulze P.C., Gielen S., et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005, 12(4):401-406.
97. Velloso C.P. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 2008, 154(3):557-568.
98. Lenk K., Erbs S., Hollriegel R., et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol 2012, 19(3):404-411.
99. Smart N.A., Larsen A.I., Le Maitre J.P., et al. Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure. Cardiol Res Pract 2011, 2011:532620.
100. Vescovo G., Volterrani M., Zennaro R., et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000, 84(4):431-437.
101. Cabello-Verrugio C., Córdova G., Salas J.D. Angiotensin II: role in skeletal muscle atrophy. Curr Protein Pept Sci 2012, 13:560-569.
102. Sukhanov S., Semprun-Prieto L., Yoshida T., et al. Angiotensin II, oxidative stress and skeletal muscle wasting. Am J Med Sci 2011, 342:143-147.
103. Tabony A.M., Yoshida T., Galvez S., et al. Angiotensin II upregulates protein phosphatase 2C alpha and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Hypertension 2011, 58:643-649.
104. Lipkin D.P., Jones D.A., Round J.M., et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988, 18(2):187-195.
105. Massie B.M., Simonini A., Sahgal P., et al. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. JAm Coll Cardiol 1996, 27(1):140-145.
106. Poole D.C., Hirai D.M., Copp S.W., et al. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol 2012, 302(5):H1050-1063.
107. von Haehling S., Steinbeck L., Doehner W., et al. Muscle wasting in heart failure: an overview. Int J Biochem Cell Biol 2013, 45(10):2257-2265.
108. Duscha B.D., Kraus W.E., Keteyian S.J., et al. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. JAm Coll Cardiol 1999, 33(7):1956-1963.
109. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. JAm Coll Cardiol 1992, 19(5):918-925.
110. Wiener D.H., Fink L.I., Maris J., et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986, 73(6):1127-1136.
111. Rosca M.G., Hoppel C.L. Mitochondrial dysfunction in heart failure. Heart Fail Rev 2013, 18(5):607-622.
112. Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992, 85(4):1364-1373.
113. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999, 20(9):683-693.
114. Majumdar S.R., Ezekowitz J.A., Lix L.M., et al. Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects. JClin Endocrinol Metab 2012, 97(4):1179-1186.
115. Murphy M.N., Mizuno M., Mitchell J.H., et al. Cardiovascular regulation by skeletal muscle reflexes in health and disease. Am J Physiol Heart Circ Physiol 2011, 301(4):H1191-1204.
116. Wang H.J., Zucker I.H., Wang W. Muscle reflex in heart failure: the role of exercise training. Front Physiol 2012, 3:398.
117. Chomsky D.B., Lang C.C., Rayos G., et al. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. JHeart Lung Transplant 1997, 16(8):846-853.
118. Guazzi M. Alveolar gas diffusion abnormalities in heart failure. JCard Fail 2008, 14(8):695-702.
119. McParland C., Resch E.F., Krishnan B., et al. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 1995, 151(4):1101-1107.
120. Waxman A.B. Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med 2001, 22(4):751-758.
121. Ukkonen H., Burwash I.G., Dafoe W., et al. Is ventilatory efficiency (VE/VCO(2) slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure?. Eur J Heart Fail 2008, 10(11):1117-1122.
122. Dhakal B.P., Murphy R.M., Lewis G.D. Exercise oscillatory ventilation in heart failure. Trends Cardiovasc Med 2012, 22(7):185-191.
123. Wasserman K., Zhang Y.Y., Gitt A., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96(7):2221-2227.
124. Oldenburg O., Bitter T., Lehmann R., et al. Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol 2011, 100(2):107-115.
125. Arena R.A., Guazzi M., Myers J., et al. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure. Med Sci Sports Exerc 2007, 39(2):213-219.
126. Laveneziana P., O'Donnell D.E., Ofir D., et al. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. JAppl Phys 2009, 106(5):1574-1583.
127. Walsh J.T., Andrews R., Johnson P., et al. Inspiratory muscle endurance in patients with chronic heart failure. Heart 1996, 76(4):332-336.
128. Cahalin L.P., Arena R., Guazzi M., et al. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther 2013, 11(2):161-177.
129. Hawkins N.M., Petrie M.C., Macdonald M.R., et al. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists. JAm Coll Cardiol 2011, 57(21):2127-2138.
130. Borghi-Silva A., Carrascosa C., Oliveira C.C., et al. Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure. Am J Physiol Heart Circ Physiol 2008, 294(6):H2465-2472.
131. Myers J., Oliveira R., Dewey F., et al. Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail 2013, 6(2):211-218.